Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder

American Journal of Surgical Pathology

Volumn 32, Issue 9, 2008, Pages 1322-1326

  Lane, Zhaoli ^a   Hansel, Donna E ^b   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adenocarcinoma; Bladder; P501S; Prostein; PSA; PSMA; Villous adenoma

Indexed keywords

P501S; PHOSPHATASE; PROSTATE SPECIFIC ACID PHOSPHATASE; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG; ACID PHOSPHATASE PROSTATE ISOENZYME; MEMBRANE PROTEIN; PROSTEIN; PROTEIN TYROSINE PHOSPHATASE; TUMOR ANTIGEN;

ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; SIGNET RING CARCINOMA; STAINING; TISSUE MICROARRAY; URINARY BLADDER ADENOMA; VILLOUS ADENOMA; ADENOCARCINOMA; BIOSYNTHESIS; BLADDER TUMOR; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; ADENOMA, VILLOUS; ANTIGENS, NEOPLASM; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN TYROSINE PHOSPHATASES; TISSUE ARRAY ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 52149118679     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181656ca0     Document Type: Article

References (15)

1. Abenoza P, Manivel C, Fraley EE. Primary adenocarcinoma of urinary bladder. Clinicopathologic study of 16 cases. Urology. 1987;29:9-14.
2. Chan TY, Epstein JI. In situ adenocarcinoma of the bladder. Am J Surg Pathol. 2001;25:892-899.
3. Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol. 1999;23:764-771.
4. Chuang AY, DeMarzo AM, Veltri RW, et al. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol. 2007;31:1246-1255.
5. Epstein JI. PSA and PAP as immunohistochemical markers in prostate cancer. Urol Clin North Am. 1993;20:757-770.
6. Epstein JI, Kuhajda FP, Lieberman PH. Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder. Hum Pathol. 1986;17:939-942.
7. Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol. 2002;117:471-477.
8. Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991;67:2165-2172.
9. Kalos M, Askaa J, Hylander BL, et al. Prostein expression is highly restricted to normal and malignant prostate tissues. Prostate. 2004;60:246-256.
10. Melicow MM. Tumors of the urinary bladder: a clinicopathological analysis of over 2500 specimens and biopsies. J Urol. 1955;74:498-521.
11. Mhawech-Fauceglia P, Zhang S, Terracciano L, et al. Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using multiple tumour tissue microarray technique. Histopathology. 2007;50: 472-483.
12. Osunkoya AO, Epstein JI. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases. Am J Surg Pathol. 2007;31:1323-1329.
13. Seibel JL, Prasad S, Weiss RE, et al. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy. Hum Pathol. 2002;33:236-241.
14. Torenbeek R, Lagendijk JH, Van Diest PJ, et al. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology. 1998;32:20-27.
15. Tran KP, Epstein JI. Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate. Am J Surg Pathol. 1996;20:1346-1350.